相关实验视频

Updated: Jun 29, 2025

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

用行政支付数据是否可以检测通用医生对腰部疼痛的补偿工人开处方的阿片类药物? 一个探索性研究

Jennifer Vo¹, Shannon Gray¹, Adrian C Traeger²

¹Healthy Working Lives Research Group, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.

Journal of occupational rehabilitation

|April 2, 2024

概括

结构化行政数据可以将阿片类药物开放与全科医生 (GP) 处方与腰部疼痛 (LBP) 工人的要求联系起来. 这种方法有助于在工人赔偿案件中监测阿片类药物使用情况.

科学领域:

职业健康职业健康职业健康职业健康
疼痛管理疼痛管理
医疗信息学医疗信息学

背景情况:

接受腰部疼痛 (LBP) 索赔的澳大利亚工人的三分之一接受阿片类止痛药.
结构化行政支付数据是可扩展的,但缺乏处方阿片类药物的直接处方联系.
该研究调查了一般医生 (GPs) 对LBP工人赔偿索赔的阿片类药物处方是否可以在行政数据中检测到.

研究的目的:

为了确定是否可以使用结构化行政支付数据识别对LBP赔偿索赔的工人的阿片类药物处方.
评估将阿片类药物开放事件与一般医生在行政数据集中的遭遇联系起来的可行性.

主要方法:

利用了维多利亚州和南澳大利亚州 (2011-2015) 接受时间损失LBP索赔的工人的数据.
结构化行政数据,以识别阿片类药物在GP遭遇后立即和同一天发放的阿片类药物.
测量了在GP访问之前的阿片类药物处置的比例和数量以及它们之间的时间间隔.

主要成果:

32.2%的采样工人 (N=4,128) 接受了阿片类药物的中位数为五次.
在43,324个阿片类药物处置中,69.9% (30,263) 立即先后发生了GP遭遇.
其中51.0%的处置发生在GP遇到的同一天.

结论:

至少三分之一用于LBP索赔的处方阿片类药物可能通过工人赔偿行政数据与GP处方有关.
这种方法显示出支持监测,审计和反系统在管理阿片类药物使用的承诺.
建议进行进一步的研究,以验证这种方法与更广泛的止痛药和从业人员类型的有效性.

关键词:

行政数据方法行政数据方法腰部疼痛腰部疼痛腰部疼痛工人赔偿的工人赔偿

更多相关视频

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Back Mechanical Sensitivity Assessment in the Rat for Mechanistic Investigation of Chronic Back Pain

Published on: August 30, 2022

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...